Go to the list of all blogs
Alicia's Avatar
published in Blogs
Mar 28, 2026
Estée Lauder (EL) Stock's -39% Drop: Merger Talks, Tariffs, and Restructuring Pressures

Estée Lauder (EL) Stock's -39% Drop: Merger Talks, Tariffs, and Restructuring Pressures

Key Takeaways

  • EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period.
  • Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats.
  • Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
  • Travel retail weakness and macroeconomic concerns amplified the downward price movement.
  • Early fiscal 2026 showed organic sales growth, but recent catalysts overshadowed positive fundamentals.

Understanding Estée Lauder (EL) and Its Place in the Market

The Estée Lauder Companies Inc. (EL) stands as a leading global manufacturer and marketer of prestige beauty products, spanning skincare, makeup, fragrance, and hair care. Its portfolio includes iconic brands such as Estée Lauder, La Mer, Clinique, MAC, and Jo Malone. Operating in over 150 countries, the company focuses on premium product innovation, direct-to-consumer channels, and partnerships with high-end retailers. In the competitive prestige beauty industry, EL maintains a strong position thanks to brand loyalty and diversification across categories and regions, especially in Asia and travel retail. That said, its exposure to global supply chains and luxury consumer spending has fueled recent stock price volatility, with tariff hikes and economic slowdowns squeezing margins and demand.

EL Stock Performance: A Look at the Last 30 Days and Quarter

In the last 30 days, EL stock has fallen sharply by about -39%, moving from around $109.47 at the end of February to $67.23 now. The decline has been highly volatile, with a steady downtrend that picked up speed in mid-March, including sharp drops on high-volume days.

Over the past quarter, the stock is down roughly -37%, from about $106.76 in early January to current levels. It stayed range-bound at first, peaking near $119 in early February before a sustained drop driven by sector-specific and macroeconomic factors. Both periods show clear downside trends with heightened volatility.

Breaking Down the Drivers Behind EL's 30-Day Decline

From what I see, the main trigger for EL's 30-day drop was the March 23 confirmation of talks for a potential business combination with Spanish beauty firm Puig, which introduced uncertainty around deal terms, valuation, and execution risks. Shares fell 7.7% that day on nearly 10 million shares of volume, then dropped another 9.9% the next session as merger doubts intensified.

Adding to the pressure, tariff headwinds—projected at $100 million for fiscal 2026 profitability—have worsened margin challenges, especially on imports from China, Europe, and other suppliers. Restructuring costs from the "Beauty Reimagined" plan, including workforce cuts, have heightened earnings uncertainty. Broader market sentiment turned negative amid consumer staples weakness, geopolitical tensions, and soft travel retail, culminating in a sharp selloff.

I also checked this using Tickeron’s AI Screener to gauge how EL stacks up against industry peers during this volatility.

What Shaped EL's Performance Over the Quarter

The quarter's -37% slide started with optimism from fiscal Q2 results in early February, which delivered 4% organic sales growth and raised EPS guidance, but a 20% single-day post-earnings drop on tariff warnings changed the trajectory. Ongoing effects from higher import duties (up to 39% on some goods), restructuring charges of $1.2-1.6 billion, and softening demand in markets like China and travel retail took over.

Macro pressures such as inflation, high interest rates, and geopolitical risks weighed on luxury beauty spending. Institutional selling during a sector rotation out of consumer staples accelerated the move, with EL lagging peers. Even with positive Q1 organic growth earlier, these headwinds overshadowed the fundamentals.

Discovering High-Performing AI Trading Tools

In my own research and trading, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI-driven trading bots out of hundreds available. These bots analyze and trade thousands of tickers across markets, using strategies like trend-following, mean reversion, or momentum across intraday to long-term horizons. Key metrics such as win rate, profit factor, and Sharpe ratio are displayed clearly. Curated by recent performance and relevance, it's a practical way to find bots that align with trends in stocks like EL. I find it valuable for spotting data-driven opportunities to enhance my toolkit.

Key Factors to Watch for EL Stock Moving Forward

One thing that stands out is the need to track updates on the Puig merger talks, including any terms or timelines, as clarity there could shift sentiment. Fiscal Q3 earnings will shed light on tariff mitigation and restructuring progress. Trends in prestige beauty demand—especially skincare and Asia-Pacific recovery—will be telling. Macro developments like interest rate changes, inflation figures, and trade policies could affect costs. Progress in "Beauty Reimagined," including cost savings, new launches, and travel retail stabilization, merits attention. Risks persist from drawn-out merger uncertainty, rising tariffs, or weaker consumer spending. I'm watching these closely for potential turning points.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: EL

Contributor

Alicia's AvatarAlicia|Beginner

EL in -2.12% downward trend, falling for three consecutive days on August 18, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EL declined for three days, in of 325 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

EL broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 19, 2026. You may want to consider a long position or call options on EL as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EL just turned positive on August 19, 2026. Looking at past instances where EL's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

EL moved above its 50-day moving average on July 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EL crossed bullishly above the 50-day moving average on August 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EL advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where EL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.690) is normal, around the industry mean (23.642). EL has a moderately high P/E Ratio (203.880) as compared to the industry average of (56.718). Projected Growth (PEG Ratio) (2.121) is also within normal values, averaging (2.919). EL has a moderately low Dividend Yield (0.014) as compared to the industry average of (0.034). P/S Ratio (2.471) is also within normal values, averaging (2.707).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.32B. The market cap for tickers in the group ranges from 81.32K to 336.3B. PG holds the highest valuation in this group at 336.3B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -5%. EL experienced the highest price growth at 18%, while YSG experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 51
Price Growth Rating: 56
SMR Rating: 70
Profit Risk Rating: 91
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
EL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which offers skin care, makeup, fragrance and hair care products

Industry HouseholdPersonalCare

Profile
Details
Industry
Household Or Personal Care
Address
767 Fifth Avenue
Phone
+1 212 572-4200
Employees
62000
Web
https://www.elcompanies.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.